Genetron Health Enters into Definitive Merger Agreement for Going Private TransactionGlobeNewsWire • 10/11/23
Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteeGlobeNewsWire • 09/02/22
Genetron Health Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the CompanyGlobeNewsWire • 08/22/22
Genetron Holdings Limited (GTH) CEO Sizhen Wang on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/03/22
Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 06/02/22
Genetron Health Receives CE Mark for FusionScan Plus Kit for Human Multi-GenesGlobeNewsWire • 06/01/22
Genetron Health to Announce First Quarter 2022 Unaudited Financial Results and Host Investor Call on June 2, 2022GlobeNewsWire • 05/23/22
Genetron Health Receives CE Mark for Human B Lymphocyte Minimal Residual Disease Detection Kit Seq-MRD®GlobeNewsWire • 04/19/22
Genetron Health Presents 17 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2022GlobeNewsWire • 04/08/22
Publication in Clinical and Translational Medicine Demonstrates Mutation Capsule™'s potential in MRD Assay DevelopmentsGlobeNewsWire • 04/07/22
Genetron Holdings Limited's (GTH) CEO Sizhen Wang on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/29/22
Genetron Health Announces Unaudited Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 03/29/22
Arima Genomics Closes Series B Financing to Support Growing Portfolio of 3D Genomics Solutions for Biomedical Research and Translational ApplicationsBusiness Wire • 03/15/22
Genetron Health to Announce Fourth Quarter and Full Year 2021 Unaudited Financial Results and Host Investor Call on March 29, 2022GlobeNewsWire • 03/09/22